By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit, LinkedIn and follow us on


Key Statistics

Ownership: Public

Web Site: Amgen
Employees: 20,000
Symbol: AMGN

Company News
Amgen (AMGN) Announces Launch Of Blood Counts And Collaboration With StoryCorps To Record And Share Stories Of Those Impacted By Multiple Myeloma 12/5/2016 9:43:15 AM
Amgen (AMGN) And Allergan (AGN) Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab 12/2/2016 8:24:17 AM
Amgen (AMGN) And Cytokinetics (CYTK) Release: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure 12/1/2016 7:10:42 AM
Amgen (AMGN), Biogen (BIIB), Celgene (CELG) Eye M&A In Trump's "Pro-Biotech" World 11/29/2016 6:47:10 AM
Arrowhead Pharma (ARWR) Announces Closing Of License And Collaboration Agreement With Amgen (AMGN) 11/21/2016 11:00:10 AM
Genentech (RHHBY) Braces for Competition From Amgen (AMGN)-Allergan (AGN) for Best-Selling Drug Avastin 11/17/2016 6:22:06 AM
Amgen (AMGN) and Novartis AG (NVS) Keep Lead in Migraine Drug Race on Positive Phase III Data 11/17/2016 5:43:27 AM
Amgen (AMGN) And Allergan (AGN) Submit Biosimilar Biologics License Application For ABP 215 To FDA 11/16/2016 6:59:31 AM
Amgen (AMGN)'s Repatha Unclogs Blocked Arteries in Key Study 11/16/2016 5:57:48 AM
Top 10 Amgen (AMGN) Scholars to Watch Set to Impact the Future of Science and Medicine 11/15/2016 6:20:26 AM